4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001810
CIK 0001369786operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:00 PM ET
Size
11.1 KB
Accession
0001562180-16-001810
Insider Transaction Report
Form 4
Krizman Anthony
Director
Transactions
- Exercise/Conversion
Common Stock
2016-02-25+460→ 6,867 total - Exercise/Conversion
Common Stock
2016-02-25+230→ 7,097 total - Exercise/Conversion
Restricted Stock Units
2016-02-25−460→ 1,381 total→ Common Stock (460 underlying) - Exercise/Conversion
Restricted Stock Units
2016-02-25−230→ 691 total→ Common Stock (230 underlying)
Footnotes (3)
- [F1]Vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning on February 25, 2016. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:00 PM ET
- Size
- 11.1 KB